Vascular Thrombosis

2

Review clinical trials related to Vascular Thrombosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation

Patients with vascular and metabolic transfemoral amputations experience substantial functional limitations and high rates of prosthetic abandonment. Although multidisciplinary inpatient rehabilitation programs have been associated with improved outcomes, evidence regarding their effectiveness in low- and middle-income countries remains limited. This study aims to evaluate the effectiveness of an inpatient rehabilitation and prosthetic training model implemented at the National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra" (INRLGII), Mexico. An ambispective cohort design will be used, including a retrospective review of patients treated between 2013 and 2025 and a prospective cohort enrolled between 2026 and 2029. The primary objective is to determine the proportion of patients who achieve functional prosthesis use after hospital discharge. Secondary objectives include identifying clinical, metabolic, functional, and psychosocial factors associated with successful prosthetic use, adherence, and abandonment.

Participants needed: 54
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Instituto Nacional de RehabilitacionUpdated: Jun 24, 2026Locations: 1Duration: 6 Months
Eligibility criteria

Unilateral transfemoral amputation secondary to vascular disease or diabetes-rel... [+3]

Current prosthesis user before admission to the INRLGII rehabilitation program. [+5]

Status: Recruiting

The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation

The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design

Participants needed: 24
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: University of California, DavisUpdated: Dec 5, 2025Locations: 1
Eligibility criteria

BMI ≥ 27 kg/m2

• History of blood clot, transient ischemic attack (TIA), stroke, angina, heart... [+8]